Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Bipolar disorder affects approximately 4.4% of U.S. adults at some point in their lives, and the depressive episodes that characterize this condition are often more disabling and longer-lasting than manic episodes. Treatment options for bipolar depression are more limited than for unipolar depression, as many standard antidepressants carry a risk of triggering mania. Emerging evidence suggests that ketamine may offer a rapid-acting option for bipolar depression, particularly when conventional approaches have not provided adequate relief.
A landmark study by Diazgranados et al. (2010), published in Archives of General Psychiatry, demonstrated that a single intravenous ketamine infusion produced rapid and robust antidepressant effects in patients with treatment-resistant bipolar depression who were maintained on mood stabilizers. Improvement was observed within 40 minutes of infusion and persisted for up to three days. A subsequent study by Zarate et al. (2012) replicated these findings, confirming the rapid antidepressant effect in bipolar depression and noting that ketamine did not induce manic symptoms in study participants.
While these results are encouraging, research on ketamine for bipolar depression is ongoing. Most studies have been small and short-term, and the long-term safety profile in this population requires further investigation. Ketamine is not FDA-approved for bipolar depression and is prescribed off-label. Any treatment must include careful psychiatric monitoring. For further reading, see our article on ketamine and bipolar depression.
1. Consultation
A 60-minute telehealth evaluation with a physician. We carefully assess your bipolar history, current medications, mood stability, and whether ketamine may be appropriate for your depressive episodes.
2. Personalized protocol
If ketamine therapy is appropriate, your physician creates a treatment plan that works alongside your existing mood stabilizer regimen. Medication is delivered to your home.
3. Close monitoring
Given the unique considerations of bipolar disorder, your physician provides ongoing follow-up with particular attention to mood stability and any signs of mood switching.
Preliminary research indicates that ketamine may help reduce depressive symptoms in bipolar disorder. Several studies have shown rapid improvement in bipolar depression scores, though ketamine is not FDA-approved for this use and careful clinical oversight is essential.
This is an important clinical concern. Studies to date have not reported a significant increase in manic switching with ketamine, particularly when patients are maintained on a mood stabilizer. However, the risk must be carefully evaluated by a physician, and treatment should include close monitoring for any mood destabilization.
No. Ketamine is FDA-approved as an anesthetic. Its use for bipolar depression is off-label and based on emerging clinical research. Esketamine (Spravato) is FDA-approved for treatment-resistant depression but not specifically for bipolar depression.
In many studies, ketamine was administered to patients who were already on mood stabilizers such as lithium or valproate. Your physician will review your current medications and make a determination about safety and suitability during your consultation.
Ready to explore ketamine therapy for bipolar depression?
Appointments often available within 24 hours.
Check Appointment Availability
